Holen Sie sich die Stockscreener-App
89.98
1.94%
1.71
Handel nachbörslich:
89.89
-0.09
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$88.27
Offen:
$88.34
24-Stunden-Volumen:
4.49M
Relative Volume:
0.98
Marktkapitalisierung:
$71.73B
Einnahmen:
$20.80B
Nettoeinkommen (Verlust:
$2.22B
KGV:
34.91
EPS:
2.5772
Netto-Cashflow:
$3.77B
1W Leistung:
+4.40%
1M Leistung:
+3.66%
6M Leistung:
+6.69%
1J Leistung:
+15.42%
1-Tages-Spanne:
$88.25
$89.98
1-Wochen-Bereich:
$86.23
$89.98
52-Wochen-Spanne:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Firmenname
Colgate Palmolive Co
Sektor
Telefon
(212) 310-2000
Adresse
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, EL, KVUE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
89.98 | 71.73B | 20.80B | 2.22B | 3.77B | 2.5772 |
PG
Procter Gamble Co
|
153.20 | 355.83B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
62.95 | 135.57B | 56.67B | 6.96B | 7.39B | 3.1265 |
EL
Estee Lauder Cos Inc
|
100.04 | 36.25B | 14.85B | -248.00M | 1.29B | -0.6966 |
KVUE
Kenvue Inc
|
17.83 | 34.25B | 15.29B | 1.62B | 1.82B | 0.8433 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-12 | Eingeleitet | Bernstein | Mkt Perform |
| 2026-04-21 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-03-31 | Herabstufung | TD Cowen | Buy → Hold |
| 2026-03-30 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2026-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-12-11 | Herabstufung | Argus | Buy → Hold |
| 2025-12-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-03 | Fortgesetzt | Piper Sandler | Neutral |
| 2024-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2024-09-24 | Eingeleitet | Piper Sandler | Overweight |
| 2024-09-16 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-09-09 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-07-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-07-23 | Eingeleitet | TD Cowen | Buy |
| 2024-06-24 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-03-01 | Fortgesetzt | Goldman | Buy |
| 2024-01-29 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-13 | Eingeleitet | Jefferies | Buy |
| 2023-10-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-09-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-02-17 | Eingeleitet | Citigroup | Buy |
| 2023-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-22 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-10-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2022-08-01 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-05-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-04-08 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-02-02 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2022-01-31 | Bestätigt | Citigroup | Neutral |
| 2022-01-31 | Bestätigt | Credit Suisse | Outperform |
| 2022-01-31 | Bestätigt | Deutsche Bank | Buy |
| 2022-01-31 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-01-31 | Bestätigt | Wells Fargo | Underweight |
| 2021-12-16 | Eingeleitet | Redburn | Neutral |
| 2021-10-05 | Fortgesetzt | BofA Securities | Neutral |
| 2021-09-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-06-24 | Eingeleitet | UBS | Buy |
| 2021-06-09 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-02-01 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2021-01-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-01-26 | Hochstufung | Berenberg | Sell → Hold |
| 2021-01-20 | Eingeleitet | Bernstein | Underperform |
| 2021-01-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-07-22 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-03-27 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-27 | Hochstufung | SunTrust | Hold → Buy |
| 2020-03-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-20 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-03 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-02-03 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-12-19 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-10-16 | Eingeleitet | Berenberg | Sell |
| 2019-04-29 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-07 | Eingeleitet | Credit Suisse | Underperform |
| 2019-02-11 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2019-01-11 | Eingeleitet | Evercore ISI | Outperform |
| 2019-01-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-10-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Herabstufung | SunTrust | Buy → Hold |
| 2018-07-30 | Herabstufung | Macquarie | Outperform → Neutral |
| 2018-05-25 | Hochstufung | Argus | Hold → Buy |
| 2018-04-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Colgate Palmolive Co Aktie (CL) Neueste Nachrichten
What Colgate Palmolive (CL)'s Branded Pet Food Push Means For Shareholders - Simply Wall Street
Crude Oil Market Reacts to Ukraine and Saudi Attacks; Colgate-Pa - GuruFocus
Colgate-Palmolive Co. Research & Ratings | CL - Barron's
Colgate-Palmolive Co. Advanced Charts | CL - Barron's
Colgate-Palmolive (CL): Can Hill’s Turn Premium Pricing Into Better Profits? - Yahoo Finance
Want to Retire on Dividends? Here Are 4 Stocks to Buy Now and Never Sell. - The Motley Fool
Colgate-Palmolive Company $CL Stock Position Raised by Wedmont Private Capital - MarketBeat
Stokes Capital Advisors LLC Purchases 19,184 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Shares Acquired by Jacobs & Co. CA - MarketBeat
Colgate-Palmolive Company $CL Stock Acquired by Apella Capital LLC - MarketBeat
Colgate-Palmolive Company $CL Position Raised by Douglas Lane & Associates LLC - MarketBeat
Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy - Yahoo Finance
Colgate-Palmolive Company $CL Stake Lifted by Cypress Asset Management Inc. TX - MarketBeat
GAMMA Investing LLC Buys 31,620 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Stock Holdings Increased by Mn Services Vermogensbeheer B.V. - MarketBeat
17,653 Colgate-Palmolive Company $CL Shares Bought by Atwood & Palmer Inc. - MarketBeat
YHB Investment Advisors Inc. Increases Stake in Colgate-Palmolive Company $CL - MarketBeat
Wells Fargo cuts target for Colgate-Palmolive stock to USD 90.00 - AD HOC NEWS
Colgate-Palmolive Company $CL Stock Acquired by Venture Visionary Partners LLC - MarketBeat
64,748 Colgate-Palmolive Company $CL Shares Acquired by Congress Asset Management Co. - MarketBeat
Why Colgate-Palmolive (CL) Is Back In The Spotlight - Simply Wall Street
Crude Oil Stocks Release Impacts Market; Colgate-Palmolive (CL) Dividend Sustainability in Focus - GuruFocus
Colgate-Palmolive Company $CL Stock Holdings Boosted by Bath Savings Trust Co - MarketBeat
Colgate-Palmolive Company $CL Shares Purchased by Canandaigua National Bank & Trust Co. - MarketBeat
Colgate-Palmolive (CL) Could Be 32% Below Fair Value After Its Dividend Update - Yahoo Finance
16,604 Colgate-Palmolive Company $CL Shares Acquired by S.E.E.D. Planning Group LLC - MarketBeat
North Point Portfolio Managers Corp OH Purchases New Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Shares Bought by Legacy Private Trust Co. - MarketBeat
Colgate-Palmolive Co (CEUX:CPAd) Valuation - GuruFocus
Colgate vs. Clorox: Which Consumer Staples Giant Holds the Edge? - Zacks Investment Research
Neville Rodie & Shaw Inc. Increases Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Ferguson Wellman Capital Management Inc. Acquires 247,112 Shares of Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive stock after-hours at EUR 76.45: plus 1.92 percent versus prior close - AD HOC NEWS
CL Maintained by Wells Fargo -- Price Target Lowered to $90 - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Cut to $90.00 by Analysts at Wells Fargo & Company - MarketBeat
Wells Fargo cuts Colgate-Palmolive stock target to USD 90 - AD HOC NEWS
Colgate-Palmolive Co (XBUL:CPA) Current Deferred Revenue : €0.00 Mil (As of Jun. 2026) - GuruFocus
Wells Fargo Adjusts Price Target on Colgate-Palmolive to $90 From $95, Maintains Equalweight Rating - marketscreener.com
116,423 Colgate-Palmolive Company $CL Shares Bought by MassMutual Private Wealth & Trust FSB - MarketBeat
Colgate-Palmolive (CL) director Brian Newman acquires 214 shares through a deferred cash retainer. - Stock Titan
A director acquires 271 Colgate-Palmolive (CL) shares through an annual retainer deferral. - Stock Titan
Colgate-Palmolive Company $CL Holdings Boosted by Confluence Investment Management LLC - MarketBeat
Colgate's Innovation and Premiumization Drive: Can Momentum Persist? - Zacks Investment Research
What Does the Dividend Mean for Colgate-Palmolive (NYSE:CL)? - Kalkine Media
Coca-Cola, Colgate-Palmolive Appoint New Customer Leaders Amid Tech and Pricing Shifts - Consumer Goods Technology
Colgate-Palmolive (CL) Dividend Reaffirmed As Fair Value Debate Comes Into Focus - simplywall.st
Oil Prices Dip Amid Middle East Tensions; Colgate-Palmolive (CL) Shows Dividend Resilience - GuruFocus
Could Colgate-Palmolive (NYSE:CL) Be the Dividend Stocks Name to Watch Today? - Kalkine Media
McCormick Readies for Q3 Earnings: What to Expect From MKC Stock? - Zacks Investment Research
Colgate-Palmolive (NYSE:CL) Stock Sale Revealed by Rep. Kevin Hern - MarketBeat
Finanzdaten der Colgate Palmolive Co-Aktie (CL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Colgate Palmolive Co-Aktie (CL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tsourapas Panagiotis | Officer |
Aug 24 '26 |
Proposed Sale |
92.05 |
10,000 |
920,477 |
0 |
| CAHILL JOHN T | Director |
Aug 06 '26 |
Option Exercise |
71.56 |
4,170 |
298,405 |
32,543 |
| CAHILL JOHN T | Director |
Aug 06 '26 |
Sale |
93.37 |
4,170 |
389,358 |
28,373 |
| CAHILL JOHN T | Director |
Aug 06 '26 |
Proposed Sale |
93.37 |
4,170 |
389,358 |
0 |
| Wallace Noel R. | Chairman, President & CEO |
Aug 05 '26 |
Sale |
92.52 |
161,021 |
14,897,904 |
362,231 |
| Wallace Noel R. | Officer |
Aug 05 '26 |
Proposed Sale |
92.52 |
161,021 |
14,897,912 |
0 |
| Wallace Noel R. | Officer |
Aug 04 '26 |
Proposed Sale |
91.92 |
161,021 |
14,800,720 |
0 |
| Wallace Noel R. | Chairman, President & CEO |
Aug 04 '26 |
Sale |
91.92 |
161,021 |
14,800,712 |
362,231 |
| CAHILLANE STEVEN A | Officer |
Aug 04 '26 |
Proposed Sale |
90.57 |
1,762 |
159,584 |
0 |
| Wallace Noel R. | Chairman, President & CEO |
Aug 04 '26 |
Option Exercise |
72.29 |
161,021 |
11,640,208 |
523,252 |
2.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):